Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer

British Journal of Cancer ◽

10.1038/sj.bjc.6603141 ◽

2006 ◽

Vol 94 (11) ◽

pp. 1604-1609 ◽

Author(s):

F Ciardiello ◽

T Troiani ◽

F Caputo ◽

M De Laurentiis ◽

G Tortora ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line Therapy ◽

Download Full-text

First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

10.1186/1471-2407-5-151 ◽

2005 ◽

Vol 5 (1) ◽

Author(s):

Djelila Allouache ◽

Sulochana R Gawande ◽

Michele Tubiana-Hulin ◽

Nicole Tubiana-Mathieu ◽

Sophie Piperno-Neumann ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line Therapy ◽

Line Therapy ◽

Locally Recurrent

Download Full-text

A multinational phase II study of Navelbine (N) and Herceptin (H) as first-line therapy for patients with HER2-positive metastatic breast cancer (HER2+ MBC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(04)90846-4 ◽

2004 ◽

Vol 2 (3) ◽

pp. 127 ◽

Author(s):

M Untch ◽

S Kahlert ◽

L Petruzelka ◽

M Martin ◽

V Guillem-Porta ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Her2 Positive ◽

First Line Therapy ◽

Download Full-text

Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-010-1002-0 ◽

2010 ◽

Vol 123 (2) ◽

pp. 427-435 ◽

Author(s):

Christopher Lobo ◽

Gilberto Lopes ◽

Odalys Baez ◽

Aurelio Castrellon ◽

Annapoorna Ferrell ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line Therapy ◽

Download Full-text

Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

Clinical & Translational Oncology ◽

10.1007/s12094-014-1210-x ◽

2014 ◽

Vol 17 (2) ◽

pp. 160-166 ◽

Author(s):

J. Salvador ◽

L. Manso ◽

J. de la Haba ◽

A. Jaen ◽

E. Ciruelos ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line Therapy ◽

Download Full-text

470 Final results of a phase II study of combination with nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy in patients with HER2-negative metastatic breast cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)70491-2 ◽

2010 ◽

Vol 8 (3) ◽

pp. 196

Author(s):

S. Glück ◽

C. Lobo ◽

G. Lopes ◽

A. Castrellon ◽

J. Hurley ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line Therapy ◽

Download Full-text

PP-7-5 phase II study of paclitaxel (P) and eplrubicin (E) as first-line therapy in patients (PTS) with metastatic breast cancer (MBC)

European Journal of Cancer ◽

10.1016/0959-8049(96)84223-7 ◽

1996 ◽

Vol 32 ◽

pp. 46

Author(s):

Ch. Thomssen ◽

H.-J. Lück ◽

A. du Bois ◽

B. Lisboa ◽

M. Untch ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line Therapy ◽

Download Full-text

Phase II study of nab-paclitaxel, bevacizumab, and gemcitabine for first-line therapy of patients with HER2-negative metastatic breast cancer (MBC)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.1089 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 1089-1089 ◽

Author(s):

S. Gluck ◽

C. Lobo ◽

I. Reis ◽

G. Lopes ◽

C. Carmody ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line Therapy ◽

Download Full-text

A phase II study of pemetrexed plus carboplatin as first-line therapy of patients with locally advanced (LA) or metastatic breast cancer (MBC): Preliminary results

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.694 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 694-694

Author(s):

A. Garin ◽

A. Manikhas ◽

M. Biakhov ◽

M. Chezhin ◽

T. Ivanchenko ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Metastatic Breast ◽

Preliminary Results ◽

First Line Therapy ◽

Download Full-text

An open-label, phase II study of weekly nab-paclitaxel as first-line therapy for patients (pts) with metastatic breast cancer (MBC): Safety update.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.1127 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 1127-1127 ◽

Author(s):

C. B. Brezden ◽

G. Cantin ◽

J. Younus ◽

L. C. Panasci ◽

P. Klimo ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line Therapy ◽

Line Therapy ◽

Open Label Phase

Download Full-text

Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study

British Journal of Cancer ◽

10.1038/sj.bjc.6602588 ◽

2005 ◽

Vol 92 (11) ◽

pp. 1989-1996 ◽

Author(s):

D Serin ◽

M Verrill ◽

A Jones ◽

T Delozier ◽

R Coleman ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Multicentre Phase ◽

First Line Therapy ◽

Download Full-text